Investing

First Look Analysts Research Calls for Monday, March 13

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. https://briefing.com

Upgrades:

> Amgen (AMGN) upgraded to Overweight from Equal Weight at Wells Fargo; tgt lowered to $265

> Eli Lilly (LLY) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $375

> JPMorgan Chase (JPM) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $155

> Moderna (MRNA) upgraded to Outperform from Market Perform at TD Cowen; tgt raised to $180

> SAGE Therapeutics (SAGE) upgraded to Outperform from Sector Perform at RBC Capital Mkts; tgt raised to $60

Downgrades:

> Allbirds (BIRD) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $1.50

> British American Tobacco (BTI) downgraded to Neutral from Overweight at JP Morgan

> Comerica (CMA) downgraded to Hold from Buy at Odeon

> Hercules Capital (HTGC) downgraded to Underperform from Mkt Perform at Keefe Bruyette; tgt lowered to $10.50

> KeyCorp (KEY) downgraded to Hold from Buy at Odeon

> Logitech Int’l SA (LOGI) downgraded to Neutral from Outperform at Credit Suisse

> Merck (MRK) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $115

> Wells Fargo (WFC) downgraded to Hold from Buy at Odeon

Others:

> Cabot (CBT) initiated with an Outperform at Credit Suisse; tgt $94

> GE HealthCare (GEHC) initiated with an Outperform at Evercore ISI; tgt $90

Get Ready To Retire (Sponsored)

Start by taking a quick retirement quiz from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes, or less.

Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.

Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future

Get started right here.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.